40 research outputs found
ã«ã€ã¹ã€ããã«ããªã¥ãŠã¿ã€ãããªã±ã«ããšãŠãœãããã«ã¬ã¯ãã±ã€ã¿ã€ããªãšããããŠã€ã¿ã€ãããããã«ã³ã¹ã«ãããã¥ãŠãã«ã¬ã¯ãããã±ã³ãã¥ãŠ
ãšãŠçŽ ãå«ãããã²ã³å
çŽ ã¯ãæ°Žã«æº¶è§£ããããããå°çè¡šå±€ã§ã¯æ°Žåãäžå¿ã«åºãååžããŠãããæ°Žåãæ§æããæ°Žã¯ãç¹ç°ãªæ§è³ªãæã€ããšãããå°çè¡šå±€ã®ç°å¢ãç 究ããäžã§éåžžã«éèŠã§ãããæ°Žã®ç¹ç°æ§ã®äžã€ãšããŠã液äœã®äžã§æ倧ã®é«ãèªé»çãæã€ããšãæããããããã®æ°Žã®é«èªé»çã«ãã£ãŠãæ°Žåã¯ããã²ã³å
çŽ ãã¯ãããšããŠå€ãã®é»è§£è³ªæåãæ°Žâ岩ç³åå¿çã«ãã£ãŠåšèŸºç°å¢ãã溶åºãããŠããã溶åºããæåã¯ãæ°Žåãäžå¿ã«å°çè¡šå±€ã§åŸªç°ãããç°å¢äžã§ã®æåã埪ç°ã¯ãã®æåãå
çŽ ã®ååŠçæ§è³ªã«äŸåãããããåæå
çŽ ãåžåé¡å
çŽ å士ã¯é¡äŒŒããæåãåãããšãç¥ãããŠãããããããããã²ã³å
çŽ ã¯æ°Žåäžã§é°ã€ãªã³ãšããŠå®å®ã«ååšãããšãã£ãç¹ã¯å
±éãããã®ã®ãçç©ãžã®èŠªåæ§ãé±ç©åã®ãããããšãã£ãç¹ã§ã¯æåãç°ãªããç¹ã«ããšãŠçŽ ã¯ããã²ã³å
çŽ ã®äžã§ãçç©èŠªåæ§ãé«ãããŸããã®ä»ã®ããã²ã³å
çŽ ãæ°Žåäžã§1䟡ã®é°ã€ãªã³ãšããŠååšããã®ã«å¯ŸããŠæµ·æŽäžã§5䟡ã®ãšãŠçŽ é
žã€ãªã³ãšããŠååšãããªã©æåãç°ãªã£ãŠããããŸãããšãŠçŽ ã«ã¯é·åæžææ žçš®ã§ãã129IãååšããŠãããæž©æ³æ°Žãæµ·åºå ç©ç©ééæ°Žãªã©ãšãã£ãå°äžæµäœã«ãããå°è³ªå¹Žä»£ã®æšå®ãå°çè¡šå±€ã§ã®ãã¬ãŒãµãŒãšããŠå©çšããç 究ããªãããŠããããããã®ããšããããšãŠçŽ ã¯å°çååŠçãªç 究ãè¡ãäžã§éåžžã«æçšãªææšãšããŠçšããããšãã§ãããããã§ããšãŠçŽ ã«çç®ããŠå°çè¡šå±€ã®æ°Žåã«é¢ããç 究ãè¡ã£ãã察象ãšããæ°Žåã¯ãå°çè¡šå±€ã®æ°Žåã®9å²ä»¥äžãå ãããæµ·æŽããšç¹ç°ãªæ§è³ªãæã€ããšãå€ããå°äžæµäœ(æž©æ³æ°Ž)ãã§ãããå°äžæµäœã®ç 究å°äžæµäœã®ç 究ã§ã¯ãåæµ·éã«ç£ããæž©æ³ã«çç®ãããåæµ·éã¯ãèªåŽã»ææ°Žåããæž©æ³ãå€ãååšããŠããå°åã§ãããè¿å¹Žã§ã¯ãæåæè¡ã®åäžãããã€ãŠã¯æž©æ³ã®ç£åºãå°é£ã§ãããšèããããŠããå°åã«ãããŠãæž©æ³ã®éçºãè¡ãããŠããããã®ãããçŸåšã§ã¯åæµ·éã®ã»ãŒå
šåã§å°äžæµäœã®è©Šææ¡åãå¯èœã§ããããŸããåæµ·éã§ã¯éå»ã®ç 究ããé«æ¿åºŠã®å¡©åãå«ãæž©æ³ã®ååšã確èªãããŠãããã®ã®ããã®æå ã«ã€ããŠã¯äžæãªç¹ãå€ãååšããŠãããããã§ãæž©æ³æ°Žã«å«ãŸããããã²ã³å
çŽ ãš129I/127Iæ¯ã枬å®ããããšã§æž©æ³æ°Žã®èµ·æºããã®æå ã«ã€ããŠã®èå¯ãè¡ã£ãããããã²ã³å
çŽ ã®åæã®çµæãå¡©çŽ æ¿åºŠã0.3ãã963mMã§ãããèçŽ æ¿åºŠã¯6ãã2500ÎŒMããšãŠçŽ æ¿åºŠã¯0.02ãã650ÎŒMãšæ¿åºŠãåºç¯å²ã§ãã£ãããŸãããã®å€ããããã²ã³å
çŽ éã®æ¿åºŠæ¯ãç®åºãããéå»ã®ç 究ã§ã¯ããã²ã³å
çŽ éã®æ¿åºŠæ¯ããæµäœã®èµ·æºãæšå®ããŠãããæ¬ç 究ã§ãåæ§ã®æ¹æ³ã§æµäœã®èµ·æºãæšå®ããããã®çµæãæ¬ç 究ã§æž¬å®ããè©Šæã®å€ããæµ·åºå ç©ç©ééæ°Žåã³ãããšæµ·æ°Žãæ··åããå€ãšäžèŽããããã®ããšãããæ¬ç 究ã§æž¬å®ããè©Šæã¯ãã®å€ããæµ·åºå ç©ç©ãæµ·æ°Žããäœããã®åœ±é¿ãåããŠããããšãæšæž¬ãããã129I/127Iæ¯ã®æž¬å®ã§ã¯å€ã0.05~0.38Ã10-12çšåºŠã§ãã£ããæ¥æ¬ã«ãããŠéå»ã®ç 究ã§æž¬å®ãããæž©æ³æ°Žãäžå¿ãšããå°äžæµäœã§ã¯129I/127Iæ¯ã¯ãã®å€ãã0.2Ã10-12çšåºŠã®å€ã§ãã£ãããã®ããã0.05ïœ0.1Ã10-12çšåºŠãšãã129I/127Iæ¯ã¯éåžžã«äœãããã®èµ·æºãå€ããã®ã§ããå¯èœæ§ã瀺åãããããŸãã129I/127Iæ¯ã®äœãè©Šæ(<0.1Ã10-12)ã®æ¡åå°ç¹ãåæµ·éã«ãããŠæ±çµ141°ãã142°ã®åäžçŽç·äžã«äœçœ®ããããšã確èªãããããã®0.05ïœ0.1Ã10-12ã®129I/127Iæ¯ãã幎代ãæšå®ãããšããã®èµ·æºãçŽ7500äžå¹Žåãã6000äžå¹Žåã«ãªãããšãæšå®ãããããã®å¹Žä»£ã«ãããŠåæµ·éã¯ãçŸåšã®åæµ·éæ±éšãšåæµ·é西éšã®éã«ã€ã¶ãã®âã¯ã©ãã¬ãŒããååšããŠãããšèããããŠãããçŸåšããã®ã€ã¶ãã®âã¯ã©ãã¬ãŒãã¯ãŠãŒã©ã·ã¢ãã¬ãŒãã«å®å
šã«æ²ã¿èŸŒãã§ããããã®éã®ãã¬ãŒããã¯ããã¯ã¹ã«ãã£ãŠçŸåšã®åæµ·éã®å°åœ¢ã圢æããããšèããããŠããããã®ãã¬ãŒãã®è¡çªæã«ãšãŠçŽ ãè±å¯ã«ä¿æããŠããæµ·åºå ç©ç©ãä»å äœãªã©ãšããŠå°æ®»ã«åã蟌ãŸããããããæž©æ³æ°Žã®æåã«åœ±é¿ãäžããŠããå¯èœæ§ã瀺åãããã129I/127Iæ¯ã®äœãè©Šæã®æ¡åå°ãåæµ·éã«ãããŠåäžçŽç·äžã«ååžããããšããã®èå¯ãè£åŒ·ããããŒã¿ã®äžã€ã§ãããæµ·æŽã®ç 究å°çè¡šå±€ã«ãããæ°Žåã®90%以äžãæµ·æŽã§ããããã®ããããšãŠçŽ ã«ãšã£ãŠãæµ·æŽã¯éèŠãªãªã¶ãŒããŒã§ãããå€ãã®ç 究ããªãããŠããããšãŠçŽ ã¯ç°å¢äžã§IO3-ãI-ãææ©ãšãŠçŽ ã®åœ¢æ
ã§äž»ã«ååšããŠãããæµ·æŽã¯ããããå
±åããç¶æ
ã§ãããçŸåšã®æµ·æŽã¯ãé
žåçãªç°å¢ã§ããããããšãŠçŽ ã¯äž»ã«IO3-ã®ååŠåœ¢æ
ã§ååšããŠããããšãç¥ãããŠãããæå
å±€ãšåŒã°ããæµ·æŽè¡šå±€ã§ã¯IO3-ã®æžå°ãšI-ã®å¢å ã確èªãããŠãããããããç±ååŠçã«ã¯ãã®å€åã¯ççŸããŠããããšãã埮çç©ã®åœ±é¿ãæšæž¬ãããŠãããéå»ã®ç 究ã§ã¯ãã®ãšãŠçŽ ã®éå
åå¿ãžã®ç¡é
žéå
èã®æŽ»æ§ã®é¢äžãå ±åãããŠãããããã¯ãIO3-ãNO3-ãšååŠåœ¢æ
ã䌌ãŠããããšããç¡é
žéå
èãNO3-ãNO2-ã«éå
ããéã«IO3-ãI-ãŸã§éå
ããŠãããšèããããããã§ããããããããšãŠçŽ ã«ç¹ç°çã«åå¿ãã埮çç©ã®ååšãç¡é
žéå
掻æ§ã倱掻ããã埮çç©ã§ãIO3-ã®éå
ãå ±åãããŠãããªã©ãäžæãªç¹ãå€ãããã®ãããæµ·æŽã«ããããšãŠçŽ ã®ååŠåœ¢æ
å€åã«ã€ããŠè©³çŽ°ã«ç 究ãè¡ã£ããæ¬ç 究ã§ã¯ãæµ·æŽäžã§ã®ãšãŠçŽ ã®ååŠåœ¢æ
å€åãåçŸããããã芳å¯ããããšã§ãšãŠçŽ ã®éå
åå¿ãèµ·ããã¡ã«ããºã ã«ã€ããŠèå¯ãè¡ã£ããå®éšæ¹æ³ã¯ãå®éã«å€©ç¶ã§æ¡åããæµ·æ°Žãæ»
èãããã€ã¢ã«ç¶ã«å¯å°ããããšã§å¹é€ããHPLC-ICP-MSã§ååŠåœ¢æ
å¥åæãè¡ã£ããããŸããæªæ¿Ÿéæµ·æ°ŽãçªèŸºã®å€ªéœå
ãå
¥å°ããæ¡ä»¶(æææ¡ä»¶)ãšããã«ãŒå
ã®ã»ãŒé®å
ããæ¡ä»¶(æææ¡ä»¶)ãšã§ãšãŠçŽ ã®ååŠåœ¢æ
å€åã®æ¯èŒãè¡ã£ãããã®çµæãæææ¡ä»¶ã§ã¯ããŸã倧ããªå€åã¯èŠãããªãã£ãããæææ¡ä»¶ã§ã¯IO3-ã®æžå°ãšI-ã®å¢å ã確èªããããããã¯ãå®éã®æµ·æŽã®æå
å±€ã«ããããšãŠçŽ ã®éå
åå¿ãšåæ§ã®å€åãèµ·ããŠãããšèããããããããããã®å®éšã§ã¯ãšãŠçŽ ã®éå
ã«é¢ããèŠå ã«ã€ããŠã¯æããã«ãªããªãã£ããããã§ãããã«æ¡ä»¶ã詳现ã«åºåãå®éšãè¡ã£ããã次ã«ãå¹é€ã«ãããæ¡ä»¶ãåäžã«ããããã«å¹é€ãã€ã³ãã¥ããŒã¿å
ã«å
æºãèšçœ®ãå®éšãè¡ã£ããå
æºã¯æ€ç©è²æçšLEDã䜿çšããããŸããå®éšã«ã¯ãå°å Žåã³æ²ŒæŽ¥ã§æ¡åããã2çš®é¡ã®æµ·æ°Žã䜿çšãããå¹é€æã®æµ·æ°Žã®æ¡ä»¶ã¯ãâ 0.2ÎŒmãã£ã«ã¿ãŒã§æ¿Ÿéããæ¿Ÿéæµ·æ°Žãâ¡ãªãŒãã¯ã¬ãŒãã§æ»
èãããªãŒãã¯ã¬ãŒãæµ·æ°Žãâ¢æçç©è³ªãæ·»å ããŠãã¯ããªã¢ã®æŽ»æ§ãæããæçç©è³ªæ·»å æµ·æ°Žãâ£å
åæé»å®³å€ãæ·»å ããŠè»é¡ã®æŽ»æ§ãæå¶ããå
åæé»å®³å€æ·»å æµ·æ°Žãâ€åŠçãè¡ããªãæªæ¿Ÿéæµ·æ°Žã®5ã€ã§å®éšãè¡ã£ãããããã®è©Šæãã€ã³ãã¥ããŒã¿å
ã§å¹é€ãããšãŠçŽ ã®ååŠåœ¢æ
å€åã«ã€ããŠèŠ³å¯ãããããã®çµæãæªæ¿Ÿéæµ·æ°Žãšæçç©è³ªæ·»å æµ·æ°Žã«ãããŠIO3-ã®å€§å¹
ãªæžå°ã確èªãããããã®ããšããIO3-ã®æžå°ã¯è»é¡ã«ãã£ãŠèµ·ããŠãããšèãããããäžæ¹ã§I-ã®å¢å ã¯ç¢ºèªã§ããªãã£ãããã®ããšãããIO3-ããI-ãžçŽæ¥éå
ãããŠããã®ã§ã¯ãªããIO3-ã®æžå°ãšI-ã®å¢å ã¯å¥ã®åå¿éçšã§ããããšãæšæž¬ããããããã§ãI-ãå¢å ããªãçç±ãèå¯ããããã®åŸåã¯ãå°å Žåã³æ²ŒæŽ¥ããããã§æ¡åãããæµ·æ°Žã§åæ§ã§ãã£ãããšããæµ·æ°Žã®æ§è³ªãåå ã§ã¯ãªããšãããããŸããå¹é€æž©åºŠãäžæãããŠãI-ã¯å¢å ããªãã£ãããšãã枩床ã«ãã圱é¿ãèãã«ãããããã§I-ãå¢å ããªãåå ã«é¢ããŠå
æºã«çç®ãããã€ã³ãã¥ããŒã¿ã«èšçœ®ããæ€ç©è²æçšLEDã¯åäžã®æ³¢é·ãæŸåºããã®ã«å¯ŸããŠã倪éœå
ã«ã¯è€æ°ã®æ³¢é·ã®å
ãååšããŠããããããããLEDã®æ³¢é·ä»¥å€ã®å
ãäœããã®åœ±é¿ãäžããŠããå¯èœæ§ãããããã倪éœå
ã§ã®å¹é€ãšLEDã§ã®å¹é€ãæ¯èŒããããã®çµæãæ¿Ÿéæµ·æ°Žã§ã¯å€ªéœå
ã»LEDãšãã«å€§ããªå€åã¯ç¢ºèªã§ããªãã£ãããæªæ¿Ÿéæµ·æ°Žã§ã¯å€ªéœå
ã»LEDãšãã«IO3-ã®æžå°ã確èªããããäžæ¹ã§I-ã®å¢å ã確èªãããã®ã¯ãæªæ¿Ÿéæµ·æ°Žã倪éœå
ã§å¹é€ããæ¡ä»¶ã®ã¿ã§ãã£ãããã®ããšãããI-ã®å¢å ã«ã¯å€ªéœå
ã®æ³¢é·ãå¿
èŠã§ãããšããããšã瀺åããããããã®ä»ã«ãI-ã®å¢å ãä¿é²ããå åãããã®ã§ã¯ãªãããšèãã倪éœå
ã®äžã§LEDã§ã®æ¡ä»¶ãšåæ§ã®â ~â€ã®æµ·æ°Žãå¹é€ããããã®çµæãæªæ¿Ÿéæµ·æ°Žãšæçç©è³ªæ·»å æµ·æ°Žã§ã¯IO3-ã®å€§å¹
ãªæžå°ã確èªããããããã¯ãLEDã§ã®å¹é€çµæãšåæ§ã®åŸåã§ãããäžæ¹ã§I-ã®å¢å åŸåã¯æªæ¿Ÿéæµ·æ°Žã§ã®ã¿ç¢ºèªããããæªæ¿Ÿéæµ·æ°Žãšæçç©è³ªæ·»å æµ·æ°Žãšã§ã®å·®ã¯ãã¯ããªã¢ã®æŽ»æ§ã®æç¡ã§ããããããã¯ããªã¢ãI-ã®å¢å ã«é¢äžããŠããããšãæšæž¬ããããã以äžã®ããšãçµ±æ¬ãããšãæµ·æŽè¡šå±€ã®æå
å±€ã§ã®ãšãŠçŽ ã®éå
åå¿ã¯ãIO3-ããI-ãžã®çŽæ¥çãªéå
ã§ã¯ãªããäžéäœãçµãè»é¡ã«ããIO3-ã®æžå°åå¿ãšãã¯ããªã¢ã«ããI-ã®å¢å åå¿ã®äºæ®µéåå¿ã§ããå¯èœæ§ã瀺åããããçµ±æ¬ãæž©æ³æ°Žåã³æµ·æ°Žã§ã®ç 究ã®çµæããšãŠçŽ ãå°äžæµäœã®èµ·æºã幎代ã®æšå®ãæ°Žåäžã®åŸ®çç©ã®æŽ»æ§èª¿æ»çã«ãããŠéåžžã«æçšãªææšãšãªãããšãããã£ãããã®ããšããããšãŠçŽ ã®ç 究ã¯å°çè¡šå±€ã®æ°Žåã®ç°å¢ãæåãç¥ãäžã§éåžžã«éèŠã§ãããšããããåŠç¿é¢å€§åŠGakushuin Universit
åå°ã®æ·±æµ·åºã«ååšããè€è²å€è²åã§ã®åŸ®çç©èª¿æ»
BE11-P72ãã¹ã¿ãŒèŠæš / ãã«ãŒã¢ãŒã¹2011ïŒ2011幎3æ7æ¥ïœ8æ¥, æ±äº¬æµ·æŽå€§åŠåå·ãã£ã³ãã¹ïŒhttp://www.godac.jamstec.go.jp/darwin/cruise/natsushima/nt05-18/ehttp://www.godac.jamstec.go.jp/darwin/cruise/natsushima/nt10-06_leg2/ehttp://www.godac.jamstec.go.jp/darwin/cruise/natsushima/nt10-13_leg2/ehttp://www.godac.jamstec.go.jp/darwin/cruise/yokosuka/yk10-10/
Donor CYP3A5 Gene Polymorphism Alone Cannot Predict Tacrolimus Intrarenal Concentration in Renal Transplant Recipients
CYP3A5 gene polymorphism in recipients plays an important role in tacrolimus blood pharmacokinetics after renal transplantation. Even though CYP3A5 protein is expressed in renal tubular cells, little is known about the influence on the tacrolimus intrarenal exposure and hence graft outcome. The aim of our study was to investigate how the tacrolimus intrarenal concentration (Ctissue) could be predicted based on donor CYP3A5 gene polymorphism in renal transplant recipients. A total of 52 Japanese renal transplant patients receiving tacrolimus were enrolled in this study. Seventy-four renal biopsy specimens were obtained at 3 months and 1 year after transplantation to determine the donor CYP3A5 polymorphism and measure the Ctissue by liquid chromatography-tandem mass spectrometry (LC-MS-MS). The tacrolimus Ctissue ranged from 52 to 399 pg/mg tissue (n = 74) and was weak but significantly correlated with tacrolimus trough concentration (C0) at 3 months after transplantation (Spearman, r = 0.3560, p = 0.0096). No significant relationship was observed between the donor CYP3A5 gene polymorphism and Ctissue or Ctissue/C0. These data showed that the tacrolimus systemic level has an impact on tacrolimus renal accumulation after renal transplantation. However, donor CYP3A5 gene polymorphism alone cannot be used to predict tacrolimus intrarenal exposure. This study may be valuable for exploring tacrolimus renal metabolism and toxicology mechanism in renal transplant recipients
Geochemical characteristics of hydrothermal fluids at Hatoma Knoll in the southern Okinawa Trough
Chemical and isotopic compositions of hydrothermal fluids from Hatoma Knoll in the southern Okinawa Trough were investigated. The hydrothermal fluids were derived from a single pure hydrothermal fluid source, but they underwent phase separation beneath the seafloor prior to venting. Only vapor-like fluids vent at the Hatoma system, and the most active area is around the center of the crater, based on the location of the maximum temperature and the lowest Clâ concentrations. Compared with other hydrothermal systems in the world, at Hatoma the pH and alkalinity, as well as the B, NH4+, K, Li, CO2, and CH4 concentrations, were higher, and the Fe and Al concentrations were lower, suggesting that the characteristics of the Hatoma hydrothermal fluids are comparable to those of the other Okinawa Trough hydrothermal fluids. Helium isotope ratios were lower than those of sediment-starved hydrothermal systems, suggesting that 4He derived from the sediment is supplied to the hydrothermal fluids in Hatoma Knoll. The carbon isotope ratios of CO2 in the hydrothermal fluids indicate an influence of organic carbon decomposition. The carbon isotope ratios of CH4 in the hydrothermal fluids imply that most of the CH4 originated from microbial methane produced in a recharge zone of the hydrothermal system. Although sediment influences are a typical feature of Okinawan Trough hydrothermal fluids, the Hatoma hydrothermal system has the lowest carbon isotope ratios of CH4 among them, which suggests that Hatoma is the most highly influenced by the sediments in the recharge zone. Thus, the degree of the sediment influences has a variable in each hydrothermal field in the Okinawa Trough